US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
CGEM holding history
Cullinan Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CGEM overviewAll 13F holders of CGEMFull Q2 2026 holdings
- Shares (Q2 2026)
- 517
- Value
- $9.41K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 517 | $9.41K | <0.1% | +15+3.0% | Added | Holders |
| Q1 2026 | 502 | $7.13K | <0.1% | +19+3.9% | Added | Holders |
| Q4 2025 | 483 | $5.00K | <0.1% | +483 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −295−100.0% | Sold out | Holders |
| Q2 2025 | 295 | $2.22K | <0.1% | −1,262−81.1% | Reduced | Holders |
| Q1 2025 | 1,557 | $11.8K | <0.1% | +1,344+631.0% | Added | Holders |
| Q4 2024 | 213 | $2.60K | <0.1% | +96+82.1% | Added | Holders |
| Q3 2024 | 117 | $1.96K | <0.1% | +12+11.4% | Added | Holders |
| Q2 2024 | 105 | $1.83K | <0.1% | −323−75.5% | Reduced | Holders |
| Q1 2024 | 428 | $7.29K | <0.1% | −76−15.1% | Reduced | Holders |
| Q4 2023 | 504 | $5.14K | <0.1% | +504 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −1,084−100.0% | Sold out | Holders |
| Q1 2023 | 1,084 | $11.1K | <0.1% | +517+91.2% | Added | Holders |
| Q4 2022 | 567 | $5.98K | <0.1% | −110−16.2% | Reduced | Holders |
| Q3 2022 | 677 | $9.00K | <0.1% | +186+37.9% | Added | Holders |
| Q2 2022 | 491 | $6.00K | <0.1% | −1,267−72.1% | Reduced | Holders |
| Q1 2022 | 1,758 | $18.0K | <0.1% | +308+21.2% | Added | Holders |
| Q4 2021 | 1,450 | $22.0K | <0.1% | +1,440+14,400.0% | Added | Holders |
| Q3 2021 | 10 | $0 | 0.0% | +10 | New | Holders |